Found vs Gala: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Found beats Gala overall, scoring 7.3/10 vs 7/10. Gala is more affordable at $149/mo vs $264/mo. Choose Found for users who want a science-backed weight loss program with beh. Choose Gala for users who want low-cost compounded tirzepatide and a built-i.
A side-by-side comparison of Found and Gala covering pricing, scores, medication types, insurance, and more to help you decide.
Found
#32 of 42Science-backed weight management platform combining GLP-1 medications with behavioral health coaching and support.
Visit FoundGala
#40 of 42Telehealth platform offering compounded semaglutide and tirzepatide at competitive pricing, plus a paid path to brand semaglutide. Differentiator: a dedicated iOS GLP-1 tracker app for users who want to log dosing, weight, and side effects in one place.
Visit Gala| Feature | Found | Gala |
|---|---|---|
| Our Score | 7.3/10 | 7/10 |
| Starting Price | $264/mo | $149/mo |
| Medication Type | Both | Both |
| Insurance Accepted | Yes | No |
| Best For | Users who want a science-backed weight loss program with behavior change support | Users who want low-cost compounded tirzepatide and a built-in iOS tracker app for daily progress logging |
| Ranking | #32 | #40 |
Pros & Cons Compared
Found
Pros
- +Active insurance coordination — Found contacts your insurer and reports which GLP-1s are covered, prior auth requirements, and estimated copay
- +10+ medication options including both compounded and brand-name (Wegovy, Zepbound, Wegovy pill) — the widest formulary of any platform
- +Typical insured copay of ~$30/mo for most members — dramatically lower than cash-pay alternatives
- +Most members start treatment within one week of completing the health questionnaire
Cons
- −Pricing is less transparent than flat-rate competitors — costs vary by insurance status and medication choice
- −The insurance navigation process adds steps and complexity compared to simple cash-pay platforms
- −Compounded medication availability may shift with FDA enforcement changes
Gala
Pros
- +Compounded tirzepatide as low as $149/mo on the longest commitment plan — among the cheapest tirz options on the market
- +$199/mo entry pricing on a 3-month plan for compounded semaglutide — competitive in the mid-tier
- +Dedicated 'Gala GLP-1 Tracker' iOS app for dosing, weight, and side-effect logging — uncommon among compounded-only platforms
- +Both semaglutide and tirzepatide available, plus a brand-name semaglutide path for users who specifically want FDA-approved
Cons
- −Brand-name semaglutide pricing ($1,299/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness
- −Newer brand (Delaware-registered, limited public company history) — less track record than established platforms like Henry Meds or Sprout
- −No published lab panels or specialty clinical oversight — state-licensed prescriber review is the standard, not differentiated
Our Verdict
Found edges out Gala with a score of 7.3/10 vs 7/10. If budget is your priority, Gala starts at $149/mo compared to Found's $264/mo. Found accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Found if you want: users who want a science-backed weight loss program with behavior change support. Choose Gala if you want: users who want low-cost compounded tirzepatide and a built-in ios tracker app for daily progress logging.